Literature DB >> 509177

Haemostatic variables associated with diabetes and its complications.

J H Fuller, H Keen, R J Jarrett, T Omer, T W Meade, R Chakrabarti, W R North, Y Stirling.   

Abstract

To study the possible role of an "increased thrombotic tendency" in the vascular complications of diabetes several tests of haemostatic function were carried out on 91 men and 63 women with diabetes aged 35-54 years and the results compared with findings in 686 men and 393 women of the same age in the Northwick Park Heart Study. Mean values for factors VII and X, fibrinogen, and platelet adhesiveness were higher in the diabetics, but mean fibrinolytic activity and whole blood platelet counts were lower. Antithrombin III values were also higher in the diabetics, which may have constituted a protective response to other changes favouring the onset of vascular disease. Diabetics with retinopathy had higher factor VII and antithrombin III values, and those with proteinuria had higher values for factor VII, fibrinogen, and platelet adhesiveness than those without these complications. These findings suggest a potentially important association between a thrombogenic tendency and vascular disease in diabetes. Nevertheless, prospective data are needed to clarify whether the haemostatic abnormalities precede the onset of clinically manifest vascular complications or are a consequence of them.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509177      PMCID: PMC1596588          DOI: 10.1136/bmj.2.6196.964

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  17 in total

1.  THE BLOOD COAGULABILITY IN DIABETIC PATIENTS.

Authors:  O EGEBERG
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.

Authors:  G R FEARNLEY; R CHAKRABARTI; P R AVIS
Journal:  Br Med J       Date:  1963-04-06

3.  Alteration of plasma antithrombin III levels in ischemic heart disease.

Authors:  R H Yue; M M Gertler; T Starr; R Koutrouby
Journal:  Thromb Haemost       Date:  1976-06-30       Impact factor: 5.249

Review 4.  Platelets and thrombosis in the development of atherosclerosis and its complications.

Authors:  J F Mustard; M A Packham; R L Kinlough-Rathbone
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

Review 5.  Population-based distributions of haemostatic variables.

Authors:  T W Meade; W R North; R Chakrabarti; A P Haines; Y Stirling
Journal:  Br Med Bull       Date:  1977-09       Impact factor: 4.291

Review 6.  Platelet functions in diabetes mellitus.

Authors:  M M Bern
Journal:  Diabetes       Date:  1978-03       Impact factor: 9.461

7.  Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.

Authors:  T W Meade; A P Haines; W R North; R Chakrabarti; D J Howarth; Y Stirling
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

8.  Letter: Fibrinolytic activity in treatment of diabetes.

Authors:  W Bogie; J George; C W Crane
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

9.  Platelet abnormalities in diabetic peripheral neuropathy.

Authors:  C B O'Malley; J D Ward; W R Timperley; N R Porter; F E Preston
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

Review 10.  Rationale for antiplatelet agents in diabetic vascular disease.

Authors:  J A Colwell; P V Halushka; K E Sarji; J Sagal
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

View more
  50 in total

1.  Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

Authors:  C Giusti; R Schiaffini; C Brufani; A Pantaleo; E M Vingolo; P Gargiulo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Thrombophilia in Patients with Hypertriglyceridemia.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease.

Authors:  T J Hendra; E Baguley; E N Harris; M H Khamashta; R C Trembath; G R Hughes; J S Yudkin
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 4.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

Review 5.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

6.  Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.

Authors:  L Poller; P K MacCallum; J M Thomson; W Kerns
Journal:  Br Heart J       Date:  1990-04

7.  Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.

Authors:  A Mormile; M Veglio; G Gruden; M Girotto; P Rossetto; P D'Este; P Cavallo-Perin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

8.  Myocardial infarct size and mortality in diabetic patients.

Authors:  D J Gwilt; M Petri; P W Lewis; M Nattrass; B L Pentecost
Journal:  Br Heart J       Date:  1985-11

9.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

Review 10.  Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.